Schedule 13G ownership disclosure

Organogenesis Holdings Inc

Common Stock, $0.0001 par value per share · CUSIP: 68621F102

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Soleus Capital Master Fund, L.P.

    Shares: 12,484,876.00 · Class: 9.9%

  • Soleus Capital, LLC

    Shares: 12,484,876.00 · Class: 9.9%

  • Soleus Capital Group, LLC

    Shares: 12,484,876.00 · Class: 9.9%

  • Soleus Capital Management, L.P.

    Shares: 12,484,876.00 · Class: 9.9%

  • Soleus GP LLC

    Shares: 12,484,876.00 · Class: 9.9%

  • Guy Levy

    Shares: 12,484,876.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-25-012185
Form type
SCHEDULE 13G/A
Filer
Organogenesis Holdings Inc.
CIK
CIK 1661181
Filed
Feb 11, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub